窝窝午夜理论片影院

【新华网】全力推进,中国中药助力首个治疗新冠肺炎中药新药
发布时间:2020-03-31

       近(jin)日,国(guo)(guo)药(yao)集团旗下中(zhong)(zhong)(zhong)国(guo)(guo)中(zhong)(zhong)(zhong)药(yao)控股有限(xian)公司(si)和(he)中(zhong)(zhong)(zhong)国(guo)(guo)中(zhong)(zhong)(zhong)医科学院(yuan)(yuan)双(shuang)方(fang)达成共识,就(jiu)首个防治新冠肺炎的中(zhong)(zhong)(zhong)药(yao)临床批件---化湿败毒颗粒临床试验批件签订合作协议。中(zhong)(zhong)(zhong)国(guo)(guo)中(zhong)(zhong)(zhong)药(yao)控股有限(xian)公司(si)接力一(yi)线科研成果,继续投入,加快(kuai)转化,争取早日实现产业化;中(zhong)(zhong)(zhong)医科学院(yuan)(yuan)国(guo)(guo)家中(zhong)(zhong)(zhong)医医疗队全体(ti)队员、后方(fang)科研攻关组一(yi)致决(jue)定(ding),以此经费(fei)设立“中(zhong)(zhong)(zhong)国(guo)(guo)中(zhong)(zhong)(zhong)医科学院(yuan)(yuan)人才培(pei)养专(zhuan)项”,培(pei)养选拔中(zhong)(zhong)(zhong)医药(yao)高素质人才,筑(zhu)牢中(zhong)(zhong)(zhong)医药(yao)传承发展根(gen)基。

       新冠(guan)肺(fei)炎(yan)疫情(qing)暴(bao)发后,中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)(yi)(yi)(yi)药行(xing)业快速反应,全面参与新冠(guan)肺(fei)炎(yan)防治。在国(guo)家中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)(yi)(yi)(yi)药管理局的(de)统一(yi)领(ling)导和部署(shu)下,1月25日,大(da)年初一(yi),中(zhong)(zhong)(zhong)(zhong)(zhong)国(guo)工(gong)(gong)程(cheng)院(yuan)院(yuan)士、中(zhong)(zhong)(zhong)(zhong)(zhong)国(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)(yi)(yi)(yi)科(ke)学院(yuan)院(yuan)长黄璐琦,率领(ling)由中(zhong)(zhong)(zhong)(zhong)(zhong)国(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)(yi)(yi)(yi)科(ke)学院(yuan)西苑医(yi)(yi)(yi)(yi)院(yuan)和广安门医(yi)(yi)(yi)(yi)院(yuan)组(zu)建的(de)第(di)一(yi)支国(guo)家中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)(yi)(yi)(yi)医(yi)(yi)(yi)(yi)疗队,奔赴武汉市金银潭医(yi)(yi)(yi)(yi)院(yuan),开展重(zhong)症新冠(guan)肺(fei)炎(yan)患(huan)者救治工(gong)(gong)作。

       医(yi)(yi)(yi)(yi)疗队边(bian)救治(zhi)、边(bian)研(yan)究、边(bian)总(zong)结,在救治(zhi)患者的(de)同时,总(zong)结临(lin)床(chuang)经验,继(ji)(ji)承古代先贤智慧,研(yan)发出化湿败毒方(fang),并获得国家(jia)药品监(jian)督(du)管理(li)局临(lin)床(chuang)试验批件(jian)(jian)。这是(shi)(shi)国家(jia)药品监(jian)督(du)管理(li)局批复的(de)首个治(zhi)疗新(xin)冠肺炎(yan)的(de)中(zhong)药临(lin)床(chuang)批件(jian)(jian),是(shi)(shi)国家(jia)首批中(zhong)医(yi)(yi)(yi)(yi)医(yi)(yi)(yi)(yi)疗队充(chong)分继(ji)(ji)承古代中(zhong)医(yi)(yi)(yi)(yi)药抗疫理(li)论(lun)成(cheng)果,总(zong)结临(lin)床(chuang)实(shi)(shi)践经验,后方(fang)科(ke)研(yan)专(zhuan)家(jia)仔细分析数(shu)据(ju),反复实(shi)(shi)验,得出的(de)防治(zhi)新(xin)冠肺炎(yan)的(de)中(zhong)药创新(xin)药物,实(shi)(shi)现了临(lin)床(chuang)实(shi)(shi)践到(dao)科(ke)研(yan)数(shu)据(ju)再到(dao)新(xin)药的(de)转化,是(shi)(shi)中(zhong)医(yi)(yi)(yi)(yi)药对此次(ci)疫病的(de)理(li)论(lun)和临(lin)床(chuang)疗效的(de)物化载体(ti)。

       国药(yao)(yao)(yao)(yao)(yao)集(ji)团(tuan)旗下中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)控股(gu)(gu)有(you)限公司作为中(zhong)(zhong)(zhong)医(yi)(yi)药(yao)(yao)(yao)(yao)(yao)行业重要(yao)央(yang)企(qi),一(yi)(yi)直(zhi)积极参(can)与新冠肺(fei)炎疫(yi)情防控,早(zao)在疫(yi)情暴发(fa)第一(yi)(yi)时(shi)间,针对金(jin)银潭医(yi)(yi)院防控物资消(xiao)耗(hao)量(liang)巨(ju)大,中(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)饮片、配(pei)方(fang)颗(ke)粒、中(zhong)(zhong)(zhong)成(cheng)药(yao)(yao)(yao)(yao)(yao)、注(zhu)射(she)液等(deng)中(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)用(yong)品(pin)严(yan)重缺(que)(que)乏(fa)现象,中(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)控股(gu)(gu)第一(yi)(yi)时(shi)间调拨中(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)配(pei)方(fang)颗(ke)粒,同时(shi)配(pei)备数套智能化配(pei)药(yao)(yao)(yao)(yao)(yao)设备,安(an)排专车驰(chi)援武汉(han),填补(bu)国家(jia)中(zhong)(zhong)(zhong)医(yi)(yi)医(yi)(yi)疗(liao)队处(chu)方(fang)用(yong)药(yao)(yao)(yao)(yao)(yao)缺(que)(que)口。两个月间,中(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)控股(gu)(gu)先后捐助四批药(yao)(yao)(yao)(yao)(yao)物,为国家(jia)中(zhong)(zhong)(zhong)医(yi)(yi)医(yi)(yi)疗(liao)队完成(cheng)救治任(ren)务提供了(le)及时(shi)可靠、充足持(chi)续的(de)物资保障。

       为落实习近平总书记“最终(zhong)战胜疫(yi)(yi)情(qing),关键要(yao)靠(kao)科技(ji)”的重要(yao)指(zhi)示(shi),双方在(zai)联(lian)手一线(xian)抗疫(yi)(yi)的同(tong)时(shi),对(dui)(dui)于疫(yi)(yi)情(qing)中(zhong)(zhong)重大(da)(da)科研(yan)成果产(chan)业(ye)(ye)转(zhuan)化再次联(lian)动。中(zhong)(zhong)国(guo)中(zhong)(zhong)药控股有限公(gong)司投入资金尽快实施后续产(chan)业(ye)(ye)化工作(zuo),与(yu)中(zhong)(zhong)国(guo)中(zhong)(zhong)医科学(xue)院共同(tong)做(zuo)好后期临床研(yan)究各(ge)项工作(zuo),同(tong)时(shi)开展国(guo)际(ji)多中(zhong)(zhong)心临床研(yan)究,加速推(tui)进化湿败毒颗粒规(gui)模化生(sheng)产(chan),切(qie)实发(fa)挥(hui)中(zhong)(zhong)医药应对(dui)(dui)新发(fa)突发(fa)重大(da)(da)公(gong)共卫生(sheng)事件(jian)的独(du)特(te)优势和作(zuo)用,为人(ren)类健康贡(gong)献中(zhong)(zhong)国(guo)中(zhong)(zhong)医药又一份礼物(wu)。中(zhong)(zhong)国(guo)中(zhong)(zhong)医科学(xue)院启动专项支(zhi)持,大(da)(da)力培养人(ren)才,鼓励更(geng)多人(ren)学(xue)习中(zhong)(zhong)医药,并针(zhen)对(dui)(dui)参(can)加赴湖北抗疫(yi)(yi)医疗队(dui)中(zhong)(zhong)医药人(ren)员的子女学(xue)习中(zhong)(zhong)医药给予重点支(zhi)持。

版权所有:国药(yao)集团
【新华网】全力推进,中国中药助力首个治疗新冠肺炎中药新药
发(fa)布时间(jian):2020-03-31

       近日,国药(yao)(yao)(yao)集团旗下中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)药(yao)(yao)(yao)控(kong)股有限(xian)公司和(he)中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)医(yi)(yi)(yi)科(ke)学(xue)院双方达成共识(shi),就首个防(fang)治新冠肺炎的中(zhong)(zhong)(zhong)药(yao)(yao)(yao)临(lin)床(chuang)批件(jian)---化湿(shi)败毒颗粒临(lin)床(chuang)试验批件(jian)签订合作协议。中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)药(yao)(yao)(yao)控(kong)股有限(xian)公司接力一线科(ke)研(yan)成果,继续(xu)投入,加快转化,争取早日实现产业化;中(zhong)(zhong)(zhong)医(yi)(yi)(yi)科(ke)学(xue)院国家中(zhong)(zhong)(zhong)医(yi)(yi)(yi)医(yi)(yi)(yi)疗(liao)队(dui)全体队(dui)员、后方科(ke)研(yan)攻关组一致决定(ding),以(yi)此经费设立“中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)医(yi)(yi)(yi)科(ke)学(xue)院人(ren)才培(pei)养专项(xiang)”,培(pei)养选拔中(zhong)(zhong)(zhong)医(yi)(yi)(yi)药(yao)(yao)(yao)高素(su)质人(ren)才,筑牢(lao)中(zhong)(zhong)(zhong)医(yi)(yi)(yi)药(yao)(yao)(yao)传承发展(zhan)根基。

       新(xin)(xin)冠肺炎(yan)疫情暴发(fa)后(hou),中(zhong)(zhong)医(yi)(yi)药(yao)行业快速反应,全(quan)面参与新(xin)(xin)冠肺炎(yan)防治。在国(guo)家中(zhong)(zhong)医(yi)(yi)药(yao)管(guan)理局的(de)统一领(ling)导和部署下(xia),1月(yue)25日(ri),大年初一,中(zhong)(zhong)国(guo)工(gong)程(cheng)院(yuan)(yuan)院(yuan)(yuan)士、中(zhong)(zhong)国(guo)中(zhong)(zhong)医(yi)(yi)科(ke)学院(yuan)(yuan)院(yuan)(yuan)长黄(huang)璐琦(qi),率领(ling)由中(zhong)(zhong)国(guo)中(zhong)(zhong)医(yi)(yi)科(ke)学院(yuan)(yuan)西(xi)苑医(yi)(yi)院(yuan)(yuan)和广(guang)安门医(yi)(yi)院(yuan)(yuan)组(zu)建的(de)第一支国(guo)家中(zhong)(zhong)医(yi)(yi)医(yi)(yi)疗队(dui),奔赴武汉市(shi)金银(yin)潭医(yi)(yi)院(yuan)(yuan),开(kai)展重症新(xin)(xin)冠肺炎(yan)患者救治工(gong)作。

       医疗(liao)队(dui)边救(jiu)治(zhi)(zhi)、边研(yan)(yan)究、边总(zong)(zong)结(jie),在救(jiu)治(zhi)(zhi)患(huan)者(zhe)的(de)(de)同时,总(zong)(zong)结(jie)临床(chuang)(chuang)经验,继(ji)承古代先贤智慧,研(yan)(yan)发出化湿败(bai)毒方(fang),并(bing)获得(de)(de)国家(jia)(jia)药(yao)(yao)品(pin)监督管理局(ju)临床(chuang)(chuang)试(shi)验批件(jian)。这是(shi)(shi)国家(jia)(jia)药(yao)(yao)品(pin)监督管理局(ju)批复(fu)的(de)(de)首个治(zhi)(zhi)疗(liao)新(xin)(xin)冠肺炎(yan)的(de)(de)中(zhong)药(yao)(yao)临床(chuang)(chuang)批件(jian),是(shi)(shi)国家(jia)(jia)首批中(zhong)医医疗(liao)队(dui)充(chong)分(fen)继(ji)承古代中(zhong)医药(yao)(yao)抗疫理论(lun)成果(guo),总(zong)(zong)结(jie)临床(chuang)(chuang)实(shi)践经验,后方(fang)科研(yan)(yan)专家(jia)(jia)仔细分(fen)析(xi)数(shu)据,反复(fu)实(shi)验,得(de)(de)出的(de)(de)防治(zhi)(zhi)新(xin)(xin)冠肺炎(yan)的(de)(de)中(zhong)药(yao)(yao)创新(xin)(xin)药(yao)(yao)物(wu)(wu),实(shi)现了临床(chuang)(chuang)实(shi)践到(dao)科研(yan)(yan)数(shu)据再到(dao)新(xin)(xin)药(yao)(yao)的(de)(de)转化,是(shi)(shi)中(zhong)医药(yao)(yao)对此次(ci)疫病的(de)(de)理论(lun)和临床(chuang)(chuang)疗(liao)效的(de)(de)物(wu)(wu)化载体。

       国(guo)(guo)药(yao)(yao)(yao)集团旗下中(zhong)(zhong)国(guo)(guo)中(zhong)(zhong)药(yao)(yao)(yao)控(kong)(kong)股有(you)限公司作为中(zhong)(zhong)医(yi)药(yao)(yao)(yao)行业(ye)重要央(yang)企,一直积极参(can)与新冠肺炎疫情防(fang)(fang)控(kong)(kong),早在疫情暴(bao)发第一时间(jian),针对金银(yin)潭医(yi)院防(fang)(fang)控(kong)(kong)物(wu)资消耗量巨大,中(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片、配(pei)(pei)方颗粒、中(zhong)(zhong)成药(yao)(yao)(yao)、注射液等中(zhong)(zhong)药(yao)(yao)(yao)用品严重缺(que)乏现象,中(zhong)(zhong)药(yao)(yao)(yao)控(kong)(kong)股第一时间(jian)调拨中(zhong)(zhong)药(yao)(yao)(yao)配(pei)(pei)方颗粒,同时配(pei)(pei)备(bei)数(shu)套(tao)智能化配(pei)(pei)药(yao)(yao)(yao)设(she)备(bei),安排专车(che)驰援武(wu)汉,填补国(guo)(guo)家中(zhong)(zhong)医(yi)医(yi)疗(liao)队(dui)处方用药(yao)(yao)(yao)缺(que)口。两个月间(jian),中(zhong)(zhong)药(yao)(yao)(yao)控(kong)(kong)股先后捐助(zhu)四批药(yao)(yao)(yao)物(wu),为国(guo)(guo)家中(zhong)(zhong)医(yi)医(yi)疗(liao)队(dui)完(wan)成救(jiu)治任务提供了(le)及时可靠、充足(zu)持续的物(wu)资保障。

       为(wei)落实(shi)习(xi)(xi)近平总(zong)书记“最终战(zhan)胜疫情,关(guan)键要靠科(ke)技(ji)”的重要指示,双方在联手一线(xian)抗(kang)疫的同时,对于疫情中(zhong)(zhong)(zhong)(zhong)(zhong)重大(da)科(ke)研成果产(chan)(chan)业转(zhuan)化(hua)再次联动(dong)。中(zhong)(zhong)(zhong)(zhong)(zhong)国(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)控股有限公司投入(ru)资金尽快实(shi)施后续产(chan)(chan)业化(hua)工作,与(yu)中(zhong)(zhong)(zhong)(zhong)(zhong)国(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)医科(ke)学院共同做好(hao)后期临床研究(jiu)各(ge)项工作,同时开展国(guo)际多(duo)中(zhong)(zhong)(zhong)(zhong)(zhong)心临床研究(jiu),加速推进化(hua)湿败毒颗粒规模化(hua)生产(chan)(chan),切实(shi)发(fa)挥(hui)中(zhong)(zhong)(zhong)(zhong)(zhong)医药(yao)应对新(xin)发(fa)突(tu)发(fa)重大(da)公共卫生事(shi)件的独特优势(shi)和作用,为(wei)人类健(jian)康贡献中(zhong)(zhong)(zhong)(zhong)(zhong)国(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)医药(yao)又(you)一份礼物。中(zhong)(zhong)(zhong)(zhong)(zhong)国(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)医科(ke)学院启(qi)动(dong)专项支持(chi),大(da)力培养人才,鼓励更(geng)多(duo)人学习(xi)(xi)中(zhong)(zhong)(zhong)(zhong)(zhong)医药(yao),并针对参加赴湖北(bei)抗(kang)疫医疗队中(zhong)(zhong)(zhong)(zhong)(zhong)医药(yao)人员的子女学习(xi)(xi)中(zhong)(zhong)(zhong)(zhong)(zhong)医药(yao)给予重点支持(chi)。

版权所有:国药集团